Eli Chapman

9.0k total citations · 4 hit papers
104 papers, 7.1k citations indexed

About

Eli Chapman is a scholar working on Molecular Biology, Organic Chemistry and Materials Chemistry. According to data from OpenAlex, Eli Chapman has authored 104 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Molecular Biology, 19 papers in Organic Chemistry and 14 papers in Materials Chemistry. Recurrent topics in Eli Chapman's work include Genomics, phytochemicals, and oxidative stress (27 papers), Heat shock proteins research (24 papers) and Protein Structure and Dynamics (13 papers). Eli Chapman is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (27 papers), Heat shock proteins research (24 papers) and Protein Structure and Dynamics (13 papers). Eli Chapman collaborates with scholars based in United States, Brazil and China. Eli Chapman's co-authors include Donna D. Zhang, Montserrat Rojo de la Vega, Chi‐Huey Wong, Pak Kin Wong, Matthew Dodson, Donna D. Zhang, Bryan Harder, Michael D. Best, Sarah R. Hanson and Tao Jiang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Eli Chapman

103 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NRF2 and the Hallmarks of Cancer

2018 1.2k citations Montserrat Rojo de la Vega, Eli Chapman et al. profile →
p62 links autophagy and Nrf2 signaling

2015 522 citations Tao Jiang, Montserrat Rojo de la Vega et al. profile →
Modulating NRF2 in Disease: Timing Is Everything

2018 395 citations Matthew Dodson, Montserrat Rojo de la Vega et al. profile →
NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8

2023 301 citations Annadurai Anandhan, Matthew Dodson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli Chapman United States	38	5.3k	980	810	802	721	104	7.1k
Shazib Pervaiz Singapore	58	5.9k 1.1×	1.5k 1.5×	600 0.7×	477 0.6×	1.0k 1.4×	176	9.9k
Kit I. Tong Japan	30	7.5k 1.4×	564 0.6×	297 0.4×	642 0.8×	1.1k 1.6×	43	9.3k
José M. Estrela Spain	44	3.1k 0.6×	648 0.7×	475 0.6×	455 0.6×	457 0.6×	88	6.5k
Masanori Kitamura Japan	53	4.2k 0.8×	791 0.8×	369 0.5×	1.2k 1.4×	986 1.4×	277	8.9k
Elias S.J. Arnér Sweden	62	11.1k 2.1×	818 0.8×	610 0.8×	1.7k 2.1×	571 0.8×	198	17.0k
Liang Cao China	44	4.0k 0.7×	954 1.0×	848 1.0×	331 0.4×	751 1.0×	241	8.0k
Michael V. Milburn United States	40	7.5k 1.4×	575 0.6×	288 0.4×	466 0.6×	742 1.0×	56	9.9k
Feng Liu China	44	3.9k 0.7×	711 0.7×	332 0.4×	269 0.3×	489 0.7×	221	6.8k
Zhiyu Li China	43	3.1k 0.6×	790 0.8×	427 0.5×	755 0.9×	450 0.6×	291	6.0k
Georg T. Wondrak United States	40	2.9k 0.5×	419 0.4×	448 0.6×	451 0.6×	339 0.5×	93	5.4k

Countries citing papers authored by Eli Chapman

Since Specialization

Citations

This map shows the geographic impact of Eli Chapman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Chapman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Chapman more than expected).

Fields of papers citing papers by Eli Chapman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Chapman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Chapman. The network helps show where Eli Chapman may publish in the future.

Co-authorship network of co-authors of Eli Chapman

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Chapman. A scholar is included among the top collaborators of Eli Chapman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Chapman. Eli Chapman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ambrose, Andrew J., Jared Sivinski, Xiaoyi Zhu, et al.. (2024). Human Hsp70 Substrate-Binding Domains Recognize Distinct Client Proteins. Biochemistry. 63(3). 251–263. 3 indexed citations

Shakya, Aryatara, Pengfei Liu, Matthew Dodson, et al.. (2023). The NRF2-p97-NRF2 negative feedback loop. Redox Biology. 65. 102839–102839. 15 indexed citations

Shakya, Aryatara, et al.. (2023). Anti-Ferroptotic Effects of Nrf2: Beyond the Antioxidant Response. Molecules and Cells. 46(3). 165–175. 61 indexed citations

Liu, Pengfei, Annadurai Anandhan, Jinjing Chen, et al.. (2022). Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease. Redox Biology. 59. 102570–102570. 48 indexed citations

Ambrose, Andrew J., Jared Sivinski, Xiaoyi Zhu, et al.. (2022). Discovery and Development of a Selective Inhibitor of the ER Resident Chaperone Grp78. Journal of Medicinal Chemistry. 66(1). 677–694. 7 indexed citations

Dodson, Matthew, Annadurai Anandhan, Cody J. Schmidlin, et al.. (2022). CHML is an NRF2 target gene that regulates mTOR function. Molecular Oncology. 16(8). 1714–1727. 2 indexed citations

Liu, Pengfei, Matthew Dodson, Hui Li, et al.. (2021). Non-canonical NRF2 activation promotes a pro-diabetic shift in hepatic glucose metabolism. Molecular Metabolism. 51. 101243–101243. 18 indexed citations

Schmidlin, Cody J., Tian Wang, Matthew Dodson, Eli Chapman, & Donna D. Zhang. (2021). FAM129B‐dependent activation of NRF2 promotes an invasive phenotype in BRAF mutant melanoma cells. Molecular Carcinogenesis. 60(5). 331–341. 17 indexed citations

Schmidlin, Cody J., Aryatara Shakya, Matthew Dodson, Eli Chapman, & Donna D. Zhang. (2021). The intricacies of NRF2 regulation in cancer. Seminars in Cancer Biology. 76. 110–119. 77 indexed citations

10.

Ambrose, Andrew J., Nhan T. Pham, Jared Sivinski, et al.. (2020). A two-step resin based approach to reveal survivin-selective fluorescent probes. RSC Chemical Biology. 2(1). 181–186. 5 indexed citations

11.

Liu, Pengfei, Matthew Dodson, Deyu Fang, Eli Chapman, & Donna D. Zhang. (2020). NRF2 negatively regulates primary ciliogenesis and hedgehog signaling. PLoS Biology. 18(2). e3000620–e3000620. 20 indexed citations

12.

Liu, Pengfei, Gang Luo, Matthew Dodson, et al.. (2020). The NRF2-LOC344887 signaling axis suppresses pulmonary fibrosis. Redox Biology. 38. 101766–101766. 38 indexed citations

13.

Zhang, Donna D. & Eli Chapman. (2020). The role of natural products in revealing NRF2 function. Natural Product Reports. 37(6). 797–826. 91 indexed citations

14.

Abdeen, Sanofar, Nilshad Salim, Anne‐Marie Ray, et al.. (2019). HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules. PMC. 1 indexed citations

15.

Tillotson, Joseph, Alison Yeomans, Carlos Jiménez‐Romero, et al.. (2018). Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with In Vivo Antitumor Activity. Clinical Cancer Research. 24(17). 4256–4270. 36 indexed citations

16.

Tao, Shasha, Montserrat Rojo de la Vega, Eli Chapman, Aikseng Ooi, & Donna D. Zhang. (2017). The effects of NRF2 modulation on the initiation and progression of chemically and genetically induced lung cancer. Molecular Carcinogenesis. 57(2). 182–192. 108 indexed citations

17.

Shen, Tao, Tao Jiang, Min Long, et al.. (2015). A Curcumin Derivative That Inhibits Vinyl Carbamate-Induced Lung Carcinogenesis via Activation of the Nrf2 Protective Response. Antioxidants and Redox Signaling. 23(8). 651–664. 68 indexed citations

18.

Ambrose, Andrew J., et al.. (2015). Unfolded DapA forms aggregates when diluted into free solution, confounding comparison with folding by the GroEL/GroES chaperonin system. FEBS Letters. 589(4). 497–499. 4 indexed citations

19.

Tao, Shasha, Shue Wang, Seyed Javad Moghaddam, et al.. (2014). Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2. Cancer Research. 74(24). 7430–7441. 241 indexed citations

20.

Chapman, Eli, George W. Farr, Renata Usaite, et al.. (2006). Global aggregation of newly translated proteins in an Escherichia coli strain deficient of the chaperonin GroEL. Proceedings of the National Academy of Sciences. 103(43). 15800–15805. 119 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact